For example, ERCC2 mutations, found in approximately 20% of muscle-invasive bladder cancers, might render these cancers sensitive to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) inhibition25. The gene discussed is PRKDC; the disease is cancer.